AS2/01 Testing and linkage to care services for 1000 people who inject drugs from Bucharest through the implementation of a three level HCV elimination strategy Raluca Teodorescu
AS2/02 Integrated harm reduction responses to HIV and viral hepatitis in the COVID-19 pandemic: a global overview Sam Shirley-Beavan AS2/03 Feasibility of HCV micro-elimination: HCV test and treatment in two harm reduction services in Milan, Italy Sara Mazzilli
AS2/04 Blood-borne virus testing in people who inject drugs with a history of sex work Eva Emanuel
AS2/05 HCV care for PWID in Europe - results from a civil society-led monitoring Rafaela Rigoni
Live Discussion